Fortress Investment Group’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Fortress Investment Group’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-66,173	Closed	-$5.29K	–	43
2023 Q1	$5.29K	Sell	66,173 -10,976	-14%	-$2.86K	﹤0.01%	33
2022 Q4	$11.7K	Hold	77,149	–	–	﹤0.01%	42
2022 Q3	$10K	Hold	77,149	–	–	﹤0.01%	74
2022 Q2	$11K	Hold	77,149	–	–	﹤0.01%	121
2022 Q1	$28K	Sell	77,149 -26,747	-26%	-$13.8K	﹤0.01%	130
2021 Q4	$100K	Hold	103,896	–	–	﹤0.01%	232
2021 Q3	$90K	Buy	+103,896	New	+$135K	0.01%	232

Fortress Investment Group's ORIAW Position: Q2 2023 in Review

Fortress Investment Group sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 66,173 shares — an estimated $5.29K sold.

Fortress Investment Group first reported a position in ORIAW in Q3 2021 and held it in 7 quarters. The position peaked at $100K in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

Fortress Investment Group reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Fortress Investment Group sold 66,173 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $5.29K.
Fortress Investment Group first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 7 quarters.
Fortress Investment Group's Orion Biotech Opportunities Corp. Warrant position peaked at $100K in Q4 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on Fortress Investment Group's 13F filing for Q2 2023, filed 14 Aug 2023.